ahlam1399
06-04-2015, 01:58 AM
**vartis tries to get U.S. ban lifted on sale of Neupogen copycat
WASHINGTON, June 3 (Reuters) - **vartis AG unit Sandoz asked a U.S. appeals court on Wednesday to lift a preliminary injunction barring it from selling its biosimilar Zarxio, a cheaper version of a drug that fends off infections in cancer patients.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46e91369/sc/21/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/1/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/1/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/2/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/2/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/3/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/ach.img (http://adchoice.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/ach.htm)http://pi.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2t.imghttp://pi2.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=rzQ8LHbGSu8:0fLEnWsTvT8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=rzQ8LHbGSu8:0fLEnWsTvT8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/rzQ8LHbGSu8
WASHINGTON, June 3 (Reuters) - **vartis AG unit Sandoz asked a U.S. appeals court on Wednesday to lift a preliminary injunction barring it from selling its biosimilar Zarxio, a cheaper version of a drug that fends off infections in cancer patients.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/46e91369/sc/21/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/1/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/1/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/2/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/2/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/3/rc.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/rc/3/rc.htm)
http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2.img (http://da.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2.htm)
http://adchoice.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/ach.img (http://adchoice.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/ach.htm)http://pi.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2t.imghttp://pi2.feedsportal.com/r/230959789395/u/49/f/654213/c/35217/s/46e91369/sc/21/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=rzQ8LHbGSu8:0fLEnWsTvT8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=rzQ8LHbGSu8:0fLEnWsTvT8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=rzQ8LHbGSu8:0fLEnWsTvT8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/rzQ8LHbGSu8